Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Head and Neck Squamous Cell Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Enrolling By InvitationNCT07016737
What this trial is testing

Immunochemotherapy ± Salvage Chemoradiation for Local Recurrence of Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Ye jinjun 79
Testing effectiveness (Phase 2)UnknownNCT01527877
What this trial is testing

Study of BKM120 in Advanced Squamous Cell Carcinoma of Head and Neck

Who this might be right for
Head Neck Cancer Squamous Cell MetastaticHead Neck Cancer Squamous Cell Recurrent
Yonsei University 53
Large-scale testing (Phase 3)Study completedNCT01156142
What this trial is testing

Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

Who this might be right for
Head and Neck CancerMucositisOral Complications of Radiation Therapy+1 more
Alliance for Clinical Trials in Oncology 155
Testing effectiveness (Phase 2)Ended earlyNCT02521870
What this trial is testing

A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Metastatic MelanomaHead Neck Cancer
Dynavax Technologies Corporation 241
Large-scale testing (Phase 3)Study completedNCT02741570
What this trial is testing

Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
Bristol-Myers Squibb 947
Testing effectiveness (Phase 2)Study completedNCT01864772
What this trial is testing

Phase II Trial of Carboplatin, 5-FU and Cetuximab in Elderly Fit (no Frailty) Patients With Recurrent/Metastatic HNSCC

Who this might be right for
Metastatic or Recurrent Head and Neck Squamous Cell Cancer
Groupe Oncologie Radiotherapie Tete et Cou 85
Testing effectiveness (Phase 2)Study completedNCT03494322
What this trial is testing

EACH: Evaluating Avelumab in Combination With Cetuximab in Head and Neck Cancer

Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma
University College, London 16
Testing effectiveness (Phase 2)Study completedNCT00639769
What this trial is testing

Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 41
Testing effectiveness (Phase 2)Study completedNCT04815720
What this trial is testing

Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)
Vaccinex Inc. 49
Testing effectiveness (Phase 2)UnknownNCT04882462
What this trial is testing

Sintilimab and Nimotuzumab Combined With Chemotherapy for the Treatment of R/M HNSCC.

Who this might be right for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
The First Affiliated Hospital of Soochow University 100
Testing effectiveness (Phase 2)Study completedNCT02762513
What this trial is testing

Expansion Trial for Axitinib In Head And Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
University of Michigan Rogel Cancer Center 29
Not applicableStudy completedNCT03032250
What this trial is testing

Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer

Who this might be right for
CaregiverMalignant Head and Neck NeoplasmParanasal Sinus Squamous Cell Carcinoma+35 more
Wake Forest University Health Sciences 35
Testing effectiveness (Phase 2)Study completedNCT00004070
What this trial is testing

Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 7
Large-scale testing (Phase 3)Active Not RecruitingNCT06525220
What this trial is testing

Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Merus B.V. 699
Early research (Phase 1)Looking for participantsNCT07156227
What this trial is testing

Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma

Who this might be right for
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Recurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell Carcinoma+27 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT00652613
What this trial is testing

Study of 3-Dimensional Conformal Radiotherapy (3D-CRT) Versus Intensity Modulated Radiotherapy (IMRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Tata Memorial Hospital 60
Large-scale testing (Phase 3)Active Not RecruitingNCT06304974
What this trial is testing

A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus01)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 497
Testing effectiveness (Phase 2)Study completedNCT03818061
What this trial is testing

Atezolizumab and Bevacizumab in Patients With Recurrent or Metastatic Squamous-cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Neoplasms
Centre Leon Berard 33
Testing effectiveness (Phase 2)Ended earlyNCT03823131
What this trial is testing

Optimizing Antitumor Immunity Using Plasmid Electroporation, Pembrolizumab, and Epacadostat

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell CarcinomaUnresectable Head and Neck Squamous Cell Carcinoma
Chase Heaton, MD 14
Not applicableNot Yet RecruitingNCT06889402
What this trial is testing

Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy

Who this might be right for
Esophageal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 600
Next Page
39